College of Life Science and Engineering, Northwest Minzu University, 730030 Lanzhou, Gansu, China.
Key Laboratory of Biotechnology and Bioengineering of State Ethnic Affairs Commission, Biomedical Research Center, Northwest Minzu University, 730030 Lanzhou, Gansu, China.
Front Biosci (Landmark Ed). 2024 Jul 25;29(7):273. doi: 10.31083/j.fbl2907273.
Understanding the mechanisms through which interferon (IFN) signaling is negatively regulated is crucial for preserving the equilibrium of innate immune reactions, as the innate immune system functions, such as the original barrier, combat threats to the host. Although the function of the encephalomyocarditis virus (EMCV) viral proteins in antagonizing innate immunity has been related to earlier studies, the precise mechanism underlying the role of viral protein 3 (VP3) in type I IFN has yet to be fully illuminated.
VP3 expression and many other adaptor molecules belonging to type I IFN pathway expression levels were evaluated using Western blotting. The IFN and other antiviral genes, such as interferon-stimulated genes (ISGs) 15 and 56, were assessed by real-time quantitative polymerase chain reaction (RT-qPCR). A 50% tissue culture infectious dose (TCID50) assay was utilized to explore the effect of VP3 on EMCV proliferation in human embryonic kidney (HEK293) cells. Co-immunoprecipitation (Co-IP) assays and confocal microscope analysis were used to investigate the underlying mechanisms mediated by VP3.
We discovered that the VP3 of EMCV acts as a suppressor of innate immune reactions. Increased levels of VP3 enhance viral reproduction through modulation of innate immune signaling pathways and suppression of antiviral responses. Additional information indicated that during viral infection, the VP3 of EMCV enhances autophagy and interacts specifically with mitochondrial antiviral signaling protein (MAVS), leading to its degradation in an autophagy pathway that relies on p62.
Our findings showed that EMCV developed a tactic to combat host antiviral defenses by using autophagy to break down a protein that controls the innate immune response following a viral infection of the host. Notably, VP3 plays an important role in this process. Overall, these discoveries may provide a novel therapeutic target for EMCV.
理解干扰素(IFN)信号负调控的机制对于维持先天免疫反应的平衡至关重要,因为先天免疫系统的功能,如原始屏障,可抵御宿主面临的威胁。尽管脑炎心肌炎病毒(EMCV)病毒蛋白在拮抗先天免疫方面的功能已与早期研究相关,但病毒蛋白 3(VP3)在 I 型 IFN 中的作用的确切机制尚未完全阐明。
使用 Western blot 评估 VP3 表达和属于 I 型 IFN 途径表达水平的许多其他衔接分子。通过实时定量聚合酶链反应(RT-qPCR)评估 IFN 和其他抗病毒基因,如干扰素刺激基因(ISGs)15 和 56。利用 50%组织培养感染剂量(TCID50)测定法研究 VP3 对 EMCV 在人胚肾(HEK293)细胞中增殖的影响。使用共免疫沉淀(Co-IP)测定法和共聚焦显微镜分析来研究由 VP3 介导的潜在机制。
我们发现 EMCV 的 VP3 作为先天免疫反应的抑制剂。VP3 水平的增加通过调节先天免疫信号通路和抑制抗病毒反应来增强病毒繁殖。更多信息表明,在病毒感染期间,EMCV 的 VP3 增强自噬并特异性与线粒体抗病毒信号蛋白(MAVS)相互作用,导致其在依赖 p62 的自噬途径中降解。
我们的研究结果表明,EMCV 通过利用自噬来破坏一种在宿主病毒感染后控制先天免疫反应的蛋白,从而开发出一种对抗宿主抗病毒防御的策略。值得注意的是,VP3 在这个过程中发挥了重要作用。总的来说,这些发现可能为 EMCV 提供一个新的治疗靶点。